Anthrax vaccines (Emergent BioSolutions)

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameAnthrax vaccines (Emergent BioSolutions)
Drug Alias NameAdenovirus serotype 4 vector vaccine against anthrax protective antigenAd4-PA-GlycosylphosphatidylinositolAd4-PAAd4-PA-1Ad4-PA-GPI
ClassificationVaccines > Development/production technology > Recombinant vector vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsAnthrax
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesEmergent Biosolutions Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEmergent Biosolutions Inc
Active IndicationsN/A
Inactive IndicationsAnthrax

Other Information

ATC CodeN/A
Related LinksN/A